Combination of High-flow Nasal Oxygen (Optiflow) and Vibrating Membrane Nebuliser (Aerogen) in the Pre-hospital Setting - Before/After Study

Study acronym: O2NAB
StatusWithdrawn
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Why the trial stopped
Le projet n'a pas obtenu l'autorisation réglementaire.

Record History

  1. Study First Submitted
The aim of this observational before/after study is to determine how to optimally administer oxygen to patients experiencing an asthma or COPD exacerbation in emergency medical services. The aim will be to determine which method will achieve the target oxygen saturation objectives: \> 95% in asthma exacerbations and between 88% and 92% (or \> 92% in ambient air or with FiO2 21%) in COPD exacerbations. The study will compare a group "before" receiving standard care with a nebulizer mask to a group "after" using a combination of a vibrating membrane nebulizer and high-flow nasal oxygen.
Trial Details
NCT Number NCT07791992
Lead Sponsor Centre Hospitalier Sud Francilien
Conditions
(from sponsor)		 Hypercapnia, Asthma Exacerbation, COPD Exacerbation
Related terms Hypercapnia
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov